Reviewing current diagnostic criteria for antibody-mediated rejection reveals that these are consensus based and empirically developed and thus potentially significantly inaccurate. Recent insights into molecular mechanisms of antibody-mediated rejection have the potential to lead to better, more precise diagnostic tools which are the prerequisite for validating and establishing improved treatments. Thus the most important thing in antibody-mediated rejection is complete understanding of the disease process.
What You'll Take Away from His Talk:
Understand the limitations in current diagnostic criteria for antibody-mediated rejection.
Appreciate the different options with potential for improving precision in diagnosing AMR.